The focus of this partnership is primarily on empowering healthcare providers and oncologists rather than direct patient interactions
CORE Diagnostics has announced a strategic collaboration with CanCertain Healthcare. This partnership aims at revolutionising how cancer patients receive personalised treatment.
Cancer is a daunting diagnosis that raises numerous questions and concerns for patients and their families. Questions about treatment options, cost, success rates, and potential side effects can create immense emotional distress. Oncologists are tasked with the challenging responsibility of swiftly determining the most effective treatment plans for each patient.
CanCertain Healthcare has set out to address this challenge with its groundbreaking CanCertain test. By providing insights into the sensitivity or resistance of a patient’s tumor to specific cancer drugs, this diagnostic tool empowers oncologists to make more informed treatment decisions. This not only saves precious time but also reduces the financial burden of ineffective treatments.
Dr Shivani Sharma, Vice President of Pathology Services & Lab Director, CORE Diagnostics said, “The CanCertain test is a game-changer in the field of oncology. It allows us to identify the most effective drugs for a patient’s unique tumor and consider their individual immunity and drug resistance. By doing so, we minimise the need for multiple rounds of different drugs, safeguard the patient’s immune system, and significantly improve the chances of successful cancer treatment.”
The focus of this partnership is primarily on empowering healthcare providers and oncologists rather than direct patient interactions. Doctors will be equipped with the vital information needed to prescribe the most appropriate and effective treatments, optimising the patient’s journey toward recovery.
Dinesh Chauhan, CEO, CORE Diagnostics, comments, “CORE Diagnostics is proud to partner with CanCertain Healthcare to enhance the precision and effectiveness of cancer treatment. Our combined expertise will not only benefit patients but also healthcare providers who strive to deliver the best possible care.”